Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Parkinson's Disease Linked to Pesticide Exposure

By Biotechdaily staff writers
Posted on 15 Apr 2008
In a recent publication researchers reported that patients with Parkinson's disease (PD) were more likely to have had a direct exposure to pesticides than their unaffected family members.

Investigators at Duke University Medical Center (Durham, NC, USA) and the University of Miami (FL, USA) conducted telephone interviews with 319 Parkinson's patients and with 296 of their relatives and other control subjects. More...
They were seeking evidence of connections between direct pesticide application, well-water consumption, and farming occupations or residences with PD while controlling age-at-examination, sex, cigarette smoking, and caffeine consumption.

They reported in the March 28, 2008, edition of the online open access journal BMC Neurology that individuals with PD were significantly more likely to report direct pesticide application than their unaffected relatives do. When classifying pesticides by functional type, both insecticides and herbicides were found to significantly increase risk of PD. Two specific insecticide classes, organochlorines and organophosphorus compounds, were significantly associated with PD. Consuming well water, living or working on a farm were not associated with PD.

"Previous studies have shown that individuals with Parkinson's disease are over twice as likely to report being exposed to pesticides as unaffected individuals,” said lead author Dr. Dana Hancock, a researcher in the program in genetics and genomics at Duke University, "but few studies have looked at this association in people from the same family or have assessed associations between specific classes of pesticides and Parkinson's disease. Biological evidence is presently insufficient to conclude that pesticide exposure causes PD. Further investigation of these specific pesticides and others may lead to identification of pertinent biological pathways influencing PD development.”


Related Links:
Duke University Medical Center
University of Miami

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.